/
STE
$210.57-$2.67 (-1.25%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$21.0B
97M shares
52-week range
$195.14 – $269.44
21% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$1.62
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.78B | $3.03B | $3.11B | $4.22B | $4.54B | $5.14B | $5.46B | $5.94B |
| Cost of revenue | $1.61B | $1.71B | $1.76B | $2.34B | $2.56B | $2.92B | $3.06B | $3.31B |
| Gross profit | $1.17B | $1.32B | $1.34B | $1.88B | $1.98B | $2.22B | $2.40B | $2.63B |
| Gross margin | 42.2% | 43.6% | 43.2% | 44.6% | 43.7% | 43.2% | 44.0% | 44.2% |
| R&D | $63.0M | $65.5M | $66.3M | $86.7M | $98.5M | $103.7M | $107.6M | $112.9M |
| Operating income | $411.0M | $537.0M | $548.4M | $477.8M | $791.1M | $836.1M | $866.6M | $1.10B |
| EBITDA | $640.0M | $736.3M | $774.0M | $1.01B | $1.23B | $1.41B | $1.36B | $1.59B |
| Net income | $304.1M | $407.7M | $397.4M | $243.9M | $107.0M | $378.2M | $614.6M | $785.1M |
| Net margin | 10.9% | 13.5% | 12.8% | 5.8% | 2.4% | 7.4% | 11.3% | 13.2% |
| EPS (diluted) | 3.56 | 4.76 | 4.63 | 2.48 | 1.07 | 3.81 | 6.20 | 7.93 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $6.4B | $11.16 | $10.90–$11.25 | 6 |
| 2028 | $6.8B | $12.19 | $11.75–$12.42 | 5 |
| 2029 | $7.2B | $13.20 | $13.06–$13.34 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$276.52
Price
$210.57
Implied upside
+31%
Peer comparison
STERIS plc
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
www.steris.com- Employees
- 17,937
- IPO / List date
- Jun 2, 1992
- HQ
- DUBLIN, L2
Held by traders on TradeandTell
No one on the platform currently holds STE.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in STE as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.20% ($2.52/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-08 | $0.6300 | 2026-06-26 |
| 2026-02-17 | $0.6300 | 2026-03-19 |
| 2025-11-18 | $0.6300 | 2025-12-18 |
| 2025-09-04 | $0.6300 | 2025-09-26 |
| 2025-06-10 | $0.5700 | 2025-06-26 |
| 2025-02-20 | $0.5700 | 2025-03-21 |
| 2024-11-19 | $0.5700 | 2024-12-19 |
| 2024-09-05 | $0.5700 | 2024-09-20 |
| 2024-06-12 | $0.5200 | 2024-06-26 |
| 2024-02-22 | $0.5200 | 2024-03-22 |
Recent trades on TradeandTell
No one on the platform has traded STE yet.
